Intermediate-density lipoprotein is a dna synthesis stimulation factor in cultured human mesangial cells

Nephron

Volumn 73, Issue 2, 1996, Pages 334-335

  Nishida, Yoji ^a   Yorioka, Noriaki ^a   Oda, Hiroaki ^a   Asakimori, Yukiteru ^a   Amimoto, Dai ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIPOPROTEIN; THYMIDINE;

BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; HUMAN; LETTER; MESANGIUM; METABOLISM; STIMULATION;

CELLS, CULTURED; DNA; GLOMERULAR MESANGIUM; HUMANS; LIPOPROTEINS; STIMULATION, CHEMICAL; THYMIDINE;

EID: 0029686116     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189072     Document Type: Article

References (16)

1. Moorhead JF. Chan MK, El-Nahas M. Var-ghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-inlerstitial disease. Lancet 1982:ii: 1309-1311.
2. Gröne EF. Abboud HE. Höhne M. Walli AK. Grönc HJ. Stüker D. Robcnck H. Wieland E. Seidel D: Actions of lipoproteins in cultured human mesangial cells: Modulation by niilo-genic vasoconstrictors. Am J Physiol 1992:263: F686-F696.
3. Wasserman J. Santiago A. Rifici V. Holthofcr H. Scharschmidt L. Epstein M. Schlondorff Ddnteractions of low density lipoprotein with rat mesangial cells. Kidney Ini 1989:35:1168-1174.
4. Coritsidis G. Rifici V, Gupta S. Rie J. Shan Z. Neugarten J. Schlondorff D: Preferential binding of oxidised LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 1991;39:858-866.
5. Takemura T. Yoshioka K. Aya N, Murakami K. Matumoto A, Itakura H, Kodama T. Suzuki H. Maki S: Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 1993;43:918-927.
6. Wheeler DC. Fernando RL. Gilletl MPT. Za-ruba J, Persaud J. Kingstone D, Varghcse Z. Moorhead JF: Characterisation of the binding of low-dcnsity lipoproteins to cultured rat mesangial cells. Nephrol Dial Transplant 1991:6: 701-708.
7. Ncugartcn J. Schlondorff D: Lipoprotein interactions with glomerular cells and matrix. Con-tcmp Issues Nephrol 1991:24:173-206.
8. Rovin BH. Tan LC: LDL stimulates mesangial fibronectin production and chemoattractanl expression. Kidney Int 1993:43:218-225.
9. Kim SB. Kang SA. Cho YJ. Park SK. Cheong I II. Lee JD. Hong CD. Park JS: Effects of low density lipoprotein on type IV collagen production by cultured rat mesangial cells. Nephron 1994:67:327-333.
10. Wheeler DC. Chana RS, Toplev N. Petersen MM. Davies M, Williams JD: Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int 1994:45: 1628-1636.
11. Nestel PJ. Fidge NH, Tan MH: Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 1982:307:329-333.
12. Attman PO. Tavella M. Knight-Gibson C. Samuelsson O. Alaupovic P: Apolipoprotein B-contaming lipoprotein particles in progressive renal insufficiency; in Guarnieri G. Panzetta G. Toigo G (cds): Metabolic and Nutritional Abnormalities in Kidney Disease. Contrib Nephrol. Basel. Karger 1992, vol 98. pp 11-19.
13. Blankenhom DH. Alaupovic P. Wickham E. Chin HP. Azen SP: Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 1990;81:470-476.
14. Ledet T. Dzoga KF. Wissler RW: Growth of rabbit aortic smooth-musclc cells cultured in media containing diabetic and hyperlipemic seaim. Diabetes 1976;25:207-215.
15. Tatami R. Mabuchi H. Ueda K. Ucda R. Haba T. Kamctani T. Ito S. Koizumi J. Ohta M. Miyamoto S. Nakavama A. Kanaya H. Oiwakc H. Genda A, Takcda R: Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 1981:64: 1174-1184.
16. Diamond JR: Analogous palhobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 1991;39(suppl 31):29-34.